Logotype for Syngene International Limited

Syngene International (SYNGENE) investor relations material

Syngene International Q1 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Syngene International Limited
Q1 25/26 earnings summary24 Jul, 2025

Executive summary

  • Q1 FY26 revenue from operations reached ₹8,745 million, up 11% year-over-year, with PAT before exceptional items at ₹867 million, a 59% increase year-over-year.

  • Operating EBITDA margin improved to 25% from 23% in Q1 FY25, with EBITDA up 19–21% year-over-year.

  • Research services drove growth, accounting for 67% of sales, with strong pilot-to-contract conversions.

  • Operational milestones included commissioning Unit 3 biologics facility, inaugurating a peptide lab, and successful US FDA GCP inspection.

  • Recognized as the most sustainable pharma/biotech company in India and among the World's Most Sustainable Companies in 2025.

Financial highlights

  • Revenue from operations rose 11% year-over-year to ₹8,745 million; constant currency growth was 7%.

  • EBITDA increased 19–21% year-over-year to ₹2,241 million; EBITDA margin at 25%.

  • PAT before exceptional items up 59% year-over-year to ₹867 million; PAT margin at 10%.

  • Net cash position at ₹10,528 million as of June 2025 after CapEx spending.

  • Sequentially, revenue declined 14% and PAT before exceptional items dropped 53% from Q4 FY25.

Outlook and guidance

  • Full-year guidance maintained: underlying revenue growth in early teens, reported growth in mid-single digits.

  • EBITDA margins expected in the mid-20s for FY26; depreciation to rise as new facilities come online.

  • Inventory adjustments in biologics expected to impact growth trajectory in coming quarters.

  • Focus on expanding integrated drug discovery, development, and manufacturing services across small and large molecules.

  • Continued investments in operational excellence, digital transformation, and ESG initiatives to drive long-term value.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Syngene International earnings date

Logotype for Syngene International Limited
Q2 20266 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Syngene International earnings date

Logotype for Syngene International Limited
Q2 20266 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Syngene International Ltd engages in the provision of contract research and manufacturing services to the pharmaceutical, nutrition, and plant biology industries. It offers a comprehensive range of services from discovery support to manufacture of life-enabling therapies. The company is involved in three principal activities: providing drug discovery research services; drug development services; and manufacture of active pharmaceutical ingredients & Intermediates, Recombinant proteins, Bioagrochemicals, Biosimilars & Biogenerics and also offering third party research & manufacturing services, including custom synthesis projects. The company was incorporated in 1993 and is headquartered in Bengaluru, India.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage